Acorda Therapeutics
ACOR
#10226
Rank
C$1.17 M
Marketcap
$0.95
Share price
0.00%
Change (1 day)
-95.33%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -C$0.37 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are C$0.11 Billion. In 2023 the company made an earning of -C$0.38 Billion a decrease over its 2022 earnings that were of -C$7.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.37 Billion-4.58%
2023 -C$0.38 Billion4848.63%
2022 -C$7.65 Million-93.25%
2021 -C$0.12 Billion2.52%
2020 -C$0.12 Billion-69.45%
2019 -C$0.37 Billion-700.62%
2018 C$60.18 M-118.02%
2017 -C$0.34 Billion805.99%
2016 -C$36.88 Million-173.88%
2015 C$49.9 M-6.58%
2014 C$53.42 M20.19%
2013 C$44.44 M18.7%
2012 C$37.44 M-26.54%
2011 C$50.97 M
2009 -C$0.12 Billion10.65%
2008 -C$0.11 Billion86.17%
2007 -C$56.51 Million68.1%
2006 -C$33.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$27.53 M-107.07%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.56 B-244.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.11 Billion-71.85%๐Ÿ‡ฉ๐Ÿ‡ช Germany
C$0.18 B-147.61%๐Ÿ‡บ๐Ÿ‡ธ USA